Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

15th International Congress on Behçet's Disease.

Fresko I.

Clin Exp Rheumatol. 2012 May-Jun;30(3 Suppl 72):S118-28. Epub 2012 Sep 25. No abstract available.

PMID:
23009706
2.

Behcet's disease.

Davatchi F.

Int J Rheum Dis. 2014 May;17(4):355-7. doi: 10.1111/1756-185X.12378. Epub 2014 Apr 25. No abstract available.

PMID:
24762121
3.

Behçet's syndrome in the 2000s: "Where is the wisdom we have lost in knowledge?"

Yazici H.

Clin Exp Rheumatol. 2016 Sep-Oct;34(6 Suppl 102):23-25. Epub 2016 Oct 25. No abstract available.

4.

Behçet's syndrome: a critical digest of the recent literature.

Hatemi G, Seyahi E, Fresko I, Hamuryudan V.

Clin Exp Rheumatol. 2012 May-Jun;30(3 Suppl 72):S80-9. Epub 2012 Sep 25. Review.

PMID:
23009740
5.

One year in review 2016: Behçet's syndrome.

Hatemi G, Seyahi E, Fresko I, Talarico R, Hamuryudan V.

Clin Exp Rheumatol. 2016 Sep-Oct;34(6 Suppl 102):10-22. Epub 2016 Oct 13. Review.

6.

Ninth International Conference on Behçet's Disease, Seoul, Korea, May 27-29, 2000.

Schirmer M, Calamia KT, Direskeneli H.

J Rheumatol. 2001 Mar;28(3):636-9. No abstract available.

PMID:
11296974
7.

Behçet's disease: general concepts and recent advances.

Okada AA.

Curr Opin Ophthalmol. 2006 Dec;17(6):551-6. Review.

PMID:
17065924
8.

Behçet's syndrome: a critical digest of the 2014-2015 literature.

Hatemi G, Seyahi E, Fresko I, Talarico R, Hamuryudan V.

Clin Exp Rheumatol. 2015 Nov-Dec;33(6 Suppl 94):S3-14. Epub 2015 Oct 19. Review.

PMID:
26487500
9.

Behçet's syndrome: a critical digest of the 2012-2013 literature.

Hatemi G, Seyahi E, Fresko I, Hamuryudan V.

Clin Exp Rheumatol. 2013 May-Jun;31(3 Suppl 77):108-17. Epub 2013 Sep 9. Review.

PMID:
24064024
10.

Behçet's syndrome: ocular features in an Australian population.

Wakefield D, McCluskey P.

Aust N Z J Ophthalmol. 1990 May;18(2):129-35.

PMID:
2390239
11.

Behçet's disease in East African patients may not be unusual and is an HLA-B51 negative condition: a case series from Mayotte (Comoros).

Liozon E, Roussin C, Puéchal X, Garou A, Valadier P, Périnet I, Raffray L, Théry Y, De Lagarde B.

Joint Bone Spine. 2011 Mar;78(2):166-70. doi: 10.1016/j.jbspin.2010.05.007. Epub 2010 Jul 6.

PMID:
20599413
12.

Results of a questionnaire on the treatment of patients with Behçet's syndrome: a trend for more intensive treatment.

Turkstra F, van Vugt RM, Dijkmans BA, Yazici Y, Yazici H.

Clin Exp Rheumatol. 2012 May-Jun;30(3 Suppl 72):S10-3. Epub 2012 Sep 25.

PMID:
22776270
13.

Learning from HSV-infected mice as a model of Behçet's disease.

Sohn S, Lee ES, Bang D.

Clin Exp Rheumatol. 2012 May-Jun;30(3 Suppl 72):S96-103. Epub 2012 Sep 25. Review.

PMID:
22766172
14.

Systemic Nocardia infection in a patient with Behçet's disease.

Pamuk GE, Pamuk ON, Tabak F, Mert A, Oztürk R, Aktuğlu Y.

Rheumatology (Oxford). 2001 May;40(5):597-9. No abstract available.

PMID:
11371678
15.

A case of Behçet's disease with development of MS-like lesions in the CNS and spinal cord.

Aoyagi R, Sakai T, Kono Y, Iguchi Y, Tsuneoka H.

Clin Exp Rheumatol. 2013 May-Jun;31(3 Suppl 77):154. Epub 2013 Sep 9. No abstract available.

PMID:
24064029
16.

Successful use of canakinumab in a patient with resistant Behçet's disease.

Cantarini L, Vitale A, Borri M, Galeazzi M, Franceschini R.

Clin Exp Rheumatol. 2012 May-Jun;30(3 Suppl 72):S115. Epub 2012 Sep 25. No abstract available.

PMID:
22776542
17.

[Comments on the pathogenesis of Behçet's disease. A key to understanding new therapies?].

Pleyer U, Hazirolan D, Stübiger N.

Ophthalmologe. 2012 Jun;109(6):563-7. doi: 10.1007/s00347-012-2586-z. German.

PMID:
22699947
18.

TNF-alpha antagonists and thalidomide for the management of gastrointestinal Behçet's syndrome refractory to the conventional treatment modalities: a case series and review of the literature.

Hatemi I, Hatemi G, Pamuk ON, Erzin Y, Celik AF.

Clin Exp Rheumatol. 2015 Nov-Dec;33(6 Suppl 94):S129-37. Epub 2015 Oct 20. Review.

PMID:
26486925
19.

Evidence-based treatment of Behçet's syndrome.

Yurdakul S.

Clin Exp Rheumatol. 2006 Sep-Oct;24(5 Suppl 42):S53-5. No abstract available. Erratum in: Clin Exp Rheumatol. 2007 May-Jun;25(3):507-8.

PMID:
17067428
20.

Efficacy of oral tacrolimus on intestinal Behcet's disease.

Matsumura K, Nakase H, Chiba T.

Inflamm Bowel Dis. 2010 Feb;16(2):188-9. doi: 10.1002/ibd.20970. No abstract available.

PMID:
19504615

Supplemental Content

Support Center